PRA Collaborates on Vaccine Studies
PRA Health Sciences (PRA) announced a collaboration with the Alliance for Multispecialty Research (AMR) to improve the efficiency of vaccine studies. AMR is a network of independently owned, geographically diverse, and experienced Clinical Research Centers of Excellence and along with PRA’s vaccine experience in Phase I-IV trials will facilitate identification of appropriate vaccine study populations, as well as address subject retention and trial conduct in this area.
Read the full release.
Truqap Combination Shines in Phase III Trial for Prostate Cancer
November 26th 2024Data from the CAPItello-281 trial show Truqap alongside abiraterone and androgen deprivation therapy achieved a statistically significant and clinically meaningful improvement in radiographic progression-free survival.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
